Paper35247166
A Change of Heart: Human Cardiac Tissue Engineering as a Platform for Drug Development.
Bremner SB and 3 others. Curr Cardiol Rep, 2022. Cited by 22 papers, by iCite.
Cite this record
ConductScience Library. A Change of Heart: Human Cardiac Tissue Engineering as a Platform for Drug Development. Papers, record 35247166. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/35247166
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics8
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Induced Pluripotent Stem Cells | Major topic |
| Pluripotent Stem Cells | Major topic |
| Arrhythmias, Cardiac | |
| Cell Differentiation | |
| Drug Development | |
| Humans | |
| Myocytes, Cardiac | |
| Tissue Engineering |
Source PubMed
Grants2
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by | Source |
|---|---|---|---|---|---|
| R01 AR076978 | NIAMS NIH HHS | United States | R01AR076978 | PubMed and NIH | NIH RePORTER |
| R01 HL149734 | NHLBI NIH HHS | United States | R01HL149734 | PubMed and NIH | NIH RePORTER |
References84
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 26843061 | Post-marketing withdrawal of 462 medicinal products because of adverse drug reactions: a systematic review of the world literature. | BMC Med | 2016 | https://conductscience.org/library/papers/26843061 | PubMed |
| 2 | 31015723 | A tissue-engineered scale model of the heart ventricle. | Nat Biomed Eng | 2018 | https://conductscience.org/library/papers/31015723 | PubMed |
| 3 | 31564645 | Fatty Acids Enhance the Maturation of Cardiomyocytes Derived from Human Pluripotent Stem Cells. | Stem Cell Reports | 2019 | https://conductscience.org/library/papers/31564645 | PubMed |
| 4 | 24424206 | The effect of cyclic stretch on maturation and 3D tissue formation of human embryonic stem cell-derived cardiomyocytes. | Biomaterials | 2014 | https://conductscience.org/library/papers/24424206 | PubMed |
| 5 | 29604261 | Afterload promotes maturation of human induced pluripotent stem cell derived cardiomyocytes in engineered heart tissues. | J Mol Cell Cardiol | 2018 | https://conductscience.org/library/papers/29604261 | PubMed |
| 6 | 27737958 | Mechanical Stress Conditioning and Electrical Stimulation Promote Contractility and Force Maturation of Induced Pluripotent Stem Cell-Derived Human Cardiac Tissue. | Circulation | 2016 | https://conductscience.org/library/papers/27737958 | PubMed |
| 7 | 34514026 | Cardiotoxicity assessment using 3D vascularized cardiac tissue consisting of human iPSC-derived cardiomyocytes and fibroblasts. | Mol Ther Methods Clin Dev | 2021 | https://conductscience.org/library/papers/34514026 | PubMed |
| 8 | 23861075 | Look back in anger - what clinical studies tell us about preclinical work. | ALTEX | 2013 | https://conductscience.org/library/papers/23861075 | PubMed |
| 9 | 24140081 | Small and large animal models in cardiac contraction research: advantages and disadvantages. | Pharmacol Ther | 2014 | https://conductscience.org/library/papers/24140081 | PubMed |
| 10 | 31385592 | Engineered Cardiac Tissues Generated in the Biowire II: A Platform for Human-Based Drug Discovery. | Toxicol Sci | 2019 | https://conductscience.org/library/papers/31385592 | PubMed |
| 11 | 33053362 | Comparison of 10 Control hPSC Lines for Drug Screening in an Engineered Heart Tissue Format. | Stem Cell Reports | 2020 | https://conductscience.org/library/papers/33053362 | PubMed |
| 12 | 29976997 | Characterization and Validation of a Human 3D Cardiac Microtissue for the Assessment of Changes in Cardiac Pathology. | Sci Rep | 2018 | https://conductscience.org/library/papers/29976997 | PubMed |
| 13 | 27600722 | Real-Time Force and Frequency Analysis of Engineered Human Heart Tissue Derived from Induced Pluripotent Stem Cells Using Magnetic Sensing. | Tissue Eng Part C Methods | 2016 | https://conductscience.org/library/papers/27600722 | PubMed |
| 14 | 29086457 | Passive Stretch Induces Structural and Functional Maturation of Engineered Heart Muscle as Predicted by Computational Modeling. | Stem Cells | 2018 | https://conductscience.org/library/papers/29086457 | PubMed |
| 15 | 31911598 | Generating ring-shaped engineered heart tissues from ventricular and atrial human pluripotent stem cell-derived cardiomyocytes. | Nat Commun | 2020 | https://conductscience.org/library/papers/31911598 | PubMed |
| 16 | 34691764 | A framework for developing sex-specific engineered heart models. | Nat Rev Mater | 2022 | https://conductscience.org/library/papers/34691764 | PubMed |
| 17 | 22092279 | A microfabricated platform to measure and manipulate the mechanics of engineered cardiac microtissues. | Tissue Eng Part A | 2012 | https://conductscience.org/library/papers/22092279 | PubMed |
| 18 | 33995650 | Progressive stretch enhances growth and maturation of 3D stem-cell-derived myocardium. | Theranostics | 2021 | https://conductscience.org/library/papers/33995650 | PubMed |
| 19 | 34096321 | Danicamtiv Enhances Systolic Function and Frank-Starling Behavior at Minimal Diastolic Cost in Engineered Human Myocardium. | J Am Heart Assoc | 2021 | https://conductscience.org/library/papers/34096321 | PubMed |
| 20 | 28765558 | Cardiac spheroids as promising in vitro models to study the human heart microenvironment. | Sci Rep | 2017 | https://conductscience.org/library/papers/28765558 | PubMed |
Cited by21
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 22 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42779869 | Curved by Design: Applying Microfluidic Principles for Nonplanar and Planar Suspended Tissue Patterning to the Development of Bladder Models with Tunable Mechanics. | bioRxiv | 2026 | https://conductscience.org/library/papers/42779869 | PubMed |
| 42455245 | The Apelin-APJ Axis in Heart Failure: Mechanistic Insights, Clinical Evidence, and Translational Challenges. | Cardiovasc Drugs Ther | 2026 | https://conductscience.org/library/papers/42455245 | PubMed |
| 41474071 | Heart-On-a-Chip with Integrated Ultrasoft Mechanosensors for Continuous Measurement of Cell- and Tissue-Scale Contractile Stresses. | Small | 2026 | https://conductscience.org/library/papers/41474071 | PubMed |
| 41373741 | Integrating Bioprinting and Increased Throughput: Next-Generation Models for Cardiac Research. | Int J Mol Sci | 2025 | https://conductscience.org/library/papers/41373741 | PubMed |
| 41351170 | UV-cure hydrogels for cardiac regeneration: a comprehensive review. | Stem Cell Res Ther | 2025 | https://conductscience.org/library/papers/41351170 | PubMed |
| 41351028 | The promise of cardiomyocyte computational models for drug safety. | Mil Med Res | 2025 | https://conductscience.org/library/papers/41351028 | PubMed |
| 41278892 | Suspended Tissue Engineering with Assemblable Microfluidics (STEAM). | bioRxiv | 2025 | https://conductscience.org/library/papers/41278892 | PubMed |
| 41239897 | Dystrophin Loss in Engineered Heart Tissues Recapitulates Clinically Relevant Aspects of Dystrophic Cardiomyopathy. | J Biomech Eng | 2026 | https://conductscience.org/library/papers/41239897 | PubMed |
| 40884127 | Tapered Pillar Design for High-Precision Force Readout in Miniaturized Engineered Heart Tissues From Human Pluripotent Stem Cells. | Adv Healthc Mater | 2025 | https://conductscience.org/library/papers/40884127 | PubMed |
| 40277603 | Biomimetic Approaches in the Development of Optimised 3D Culture Environments for Drug Discovery in Cardiac Disease. | Biomimetics (Basel) | 2025 | https://conductscience.org/library/papers/40277603 | PubMed |
| 39768038 | Advancing 3D Engineered In Vitro Models for Heart Failure Research: Key Features and Considerations. | Bioengineering (Basel) | 2024 | https://conductscience.org/library/papers/39768038 | PubMed |
| 38643271 | Analysis of the role of perfusion, mechanical, and electrical stimulation in bioreactors for cardiac tissue engineering. | Bioprocess Biosyst Eng | 2024 | https://conductscience.org/library/papers/38643271 | PubMed |
| 38241367 | Engineered cocultures of iPSC-derived atrial cardiomyocytes and atrial fibroblasts for modeling atrial fibrillation. | Sci Adv | 2024 | https://conductscience.org/library/papers/38241367 | PubMed |
| 38046544 | FRESH™ 3D bioprinted cardiac tissue, a bioengineered platform for in vitro pharmacology. | APL Bioeng | 2023 | https://conductscience.org/library/papers/38046544 | PubMed |
| 37809996 | A review of protocols for engineering human cardiac organoids. | Heliyon | 2023 | https://conductscience.org/library/papers/37809996 | PubMed |
| 37627245 | Three-Dimensional Bioprinting in Cardiovascular Disease: Current Status and Future Directions. | Biomolecules | 2023 | https://conductscience.org/library/papers/37627245 | PubMed |
| 37624669 | Arrhythmic Effects Evaluated on Caenorhabditis elegans: The Case of Polypyrrole Nanoparticles. | ACS Nano | 2023 | https://conductscience.org/library/papers/37624669 | PubMed |
| 37415188 | Sandwich-like electro-conductive polyurethane-based gelatin/soybean oil nanofibrous scaffolds with a targeted release of simvastatin for cardiac tissue engineering. | J Biol Eng | 2023 | https://conductscience.org/library/papers/37415188 | PubMed |
| 37034250 | Development of three-dimensional primary human myospheres as culture model of skeletal muscle cells for metabolic studies. | Front Bioeng Biotechnol | 2023 | https://conductscience.org/library/papers/37034250 | PubMed |
| 36982261 | Advances in 3D Organoid Models for Stem Cell-Based Cardiac Regeneration. | Int J Mol Sci | 2023 | https://conductscience.org/library/papers/36982261 | PubMed |
Genes5
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes | Source |
|---|---|---|---|---|
| AGT | 183 | PubTator's text mining | https://conductscience.org/library/genes/183 | NCBI Gene |
| ENPP2 | 5168 | PubTator's text mining | https://conductscience.org/library/genes/5168 | NCBI Gene |
| ERG | 2078 | PubTator's text mining | https://conductscience.org/library/genes/2078 | NCBI Gene |
| KCNH2 | 3757 | PubTator's text mining | https://conductscience.org/library/genes/3757 | NCBI Gene |
| TGFB1 | 7040 | PubTator's text mining | https://conductscience.org/library/genes/7040 | NCBI Gene |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/35247166
GET https://conductscience.org/api/papers/v1/35247166/references?page=2